Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04007913 · ClinicalTrials.gov registry record · NA
Incorporating teleCBIT Into a Hospital-Based Tic Program
A NA study, sponsored by San Jose State University.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT04007913: Completed NA study, sponsored by San Jose State University.
NCT04007913 is a NA study that has completed, run by San Jose State University. The registered enrollment target is 31 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04007913, a NA study, has completed, sponsored by San Jose State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
This is a single-arm open trial of Comprehensive Behavioral Intervention for Tics (CBIT) delivered to pediatric and adult patients with persistent tic disorders in their homes via videoconferencing (i.e., teleCBIT). All participants who enroll will receive teleCBIT.
Primary Outcome
YGTSS Tic Severity Score (0-50) as rated by independent evaluator. Higher scores indicate more severe tics.
Interventions
- BEHAVIORAL teleCBIT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2016-09-21 |
| Est. Completion | 2019-06-15 |
| Phase | NA |
What the finished NCT04007913 record still lists
NCT04007913 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which teleCBIT is the first listed.
NCT04007913 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04007913 about?
NCT04007913 is a clinical study titled "Incorporating teleCBIT Into a Hospital-Based Tic Program". This is a single-arm open trial of Comprehensive Behavioral Intervention for Tics (CBIT) delivered to pediatric and adult patients with persistent tic disorders in their homes via videoconferencing (i.e., teleCBIT). All participants who enroll will receive teleCBIT.
What is the current status of trial NCT04007913?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2016-09-21. Estimated completion is 2019-06-15.
What interventions are being tested in trial NCT04007913?
The interventions under investigation include: teleCBIT (BEHAVIORAL).
Who is sponsoring clinical trial NCT04007913?
This trial is sponsored by San Jose State University, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04007913's enrollment target sits among peer trials
31 1592nd of 2000 higher than 408 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI